TY - JOUR
T1 - Ignored and undervalued in public health
T2 - a systematic review of health state utility values associated with syphilis infection
AU - Miao, Patrick
AU - Terris-Prestholt, Fern
AU - Fairley, Christopher K.
AU - Tucker, Joseph D.
AU - Wiseman, Virginia
AU - Mayaud, Philippe
AU - Zhang, Ying
AU - Rowley, Jane
AU - Gottlieb, Sami
AU - Korenromp, Eline L.
AU - Watts, Caroline G.
AU - Ong, Jason J.
N1 - Funding Information:
JJO is supported by the Australian National Health and Medical Research Council (NHMRC) Emerging Leader Fellowship (GNT1193955).
Funding Information:
We thank Dr Mae Dirac (University of Washington) for providing insight both into the estimation processes used by the Global Burden of Disease team and also into the future directions for syphilis burden of disease estimation.
Publisher Copyright:
© The Author(s) 2024.
PY - 2024/12
Y1 - 2024/12
N2 - Background: Syphilis is a sexually transmitted infection causing significant global morbidity and mortality. To inform policymaking and economic evaluation studies for syphilis, we summarised utility and disability weights for health states associated with syphilis. Methods: We conducted a systematic review, searching six databases for economic evaluations and primary valuation studies related to syphilis from January 2000 to February 2022. We extracted health state utility values or disability weights, including identification of how these were derived. The study was registered in the international prospective register of systematic reviews (PROSPERO, CRD42021230035). Findings: Of 3401 studies screened, 22 economic evaluations, two primary studies providing condition-specific measures, and 13 burden of disease studies were included. Fifteen economic evaluations reported outcomes as disability-adjusted life years (DALYs) and seven reported quality-adjusted life years (QALYs). Fourteen of 15 economic evaluations that used DALYS based their values on the original Global Burden of Disease (GBD) study from 1990 (published in 1996). For the seven QALY-related economic evaluations, the methodology varied between studies, with some studies using assumptions and others creating utility weights or converting them from disability weights. Interpretation: We found a limited evidence base for the valuation of health states for syphilis, a lack of transparency for the development of existing health state utility values, and inconsistencies in the application of these values to estimate DALYs and QALYs. Further research is required to expand the evidence base so that policymakers can access accurate and well-informed economic evaluations to allocate resources to address syphilis and implement syphilis programs that are cost-effective.
AB - Background: Syphilis is a sexually transmitted infection causing significant global morbidity and mortality. To inform policymaking and economic evaluation studies for syphilis, we summarised utility and disability weights for health states associated with syphilis. Methods: We conducted a systematic review, searching six databases for economic evaluations and primary valuation studies related to syphilis from January 2000 to February 2022. We extracted health state utility values or disability weights, including identification of how these were derived. The study was registered in the international prospective register of systematic reviews (PROSPERO, CRD42021230035). Findings: Of 3401 studies screened, 22 economic evaluations, two primary studies providing condition-specific measures, and 13 burden of disease studies were included. Fifteen economic evaluations reported outcomes as disability-adjusted life years (DALYs) and seven reported quality-adjusted life years (QALYs). Fourteen of 15 economic evaluations that used DALYS based their values on the original Global Burden of Disease (GBD) study from 1990 (published in 1996). For the seven QALY-related economic evaluations, the methodology varied between studies, with some studies using assumptions and others creating utility weights or converting them from disability weights. Interpretation: We found a limited evidence base for the valuation of health states for syphilis, a lack of transparency for the development of existing health state utility values, and inconsistencies in the application of these values to estimate DALYs and QALYs. Further research is required to expand the evidence base so that policymakers can access accurate and well-informed economic evaluations to allocate resources to address syphilis and implement syphilis programs that are cost-effective.
KW - Disability weight
KW - Disability-adjusted life year
KW - Health economics
KW - Health state utility value
KW - Quality of life
KW - Quality-adjusted life year
KW - Syphilis
KW - Utility weight
UR - http://www.scopus.com/inward/record.url?scp=85185103868&partnerID=8YFLogxK
U2 - 10.1186/s12955-024-02234-1
DO - 10.1186/s12955-024-02234-1
M3 - Review Article
C2 - 38350925
AN - SCOPUS:85185103868
SN - 1477-7525
VL - 22
JO - Health and Quality of Life Outcomes
JF - Health and Quality of Life Outcomes
IS - 1
M1 - 17
ER -